Bionano Genomics, Inc. provided preliminary revenue guidance for the fourth quarter and full year ended December 31, 2022. Revenues for the fourth quarter 2022 are expected to be in the range of $8.1 million to $8.4 million, an estimated increase of 12% to 16% compared to $7.2 million in the third quarter of 2022 and an estimated increase of 27% to 33% compared to the fourth quarter of 2021.

Full year 2022 revenue is expected to be in the range of $27.7 million and $28.0 million, an estimated increase of between 54% and 56% compared to 2021.